-52%

est. 2Y upside i

Series C

Stage: exit. Country: Germany

Rank

#3290

Sector

Teledentistry

Est. Liquidity

~2Y

Data Quality

Data: Low

Joining PlusDental at this stage carries high risk.

Last updated: July 21, 2026

Bull (10%)+20%

If Straumann integration drives synergies and revenue stabilizes, the company may achieve modest growth from a low base. Entry valuation of $138M could support a 20% upside if multiple holds.

Base (45%)-20%

Continued competitive pressure from Align Technology and market saturation lead to stagnant revenue and a declining multiple. Preference overhang of $88M dilutes common further, resulting in a 20% loss.

Bear (45%)-100%

Severe competition and inability to raise capital cause a distressed exit below $88M total funding, wiping out common equity entirely. Layoffs and negative news confirm high downside risk.

Est. time to liquidity~2.0 years

Preference Stack Risk

severe

Funding Intensity

6380%

Total funding of $88M against $138M valuation implies 64% overhang; common stock is subordinate to $88M of preferred.

Dilution Risk

high

Likely need to raise more capital within 2 years due to cash burn, further diluting common equity by around 20%.

Secondary Liquidity

none

No secondary market activity; equity is illiquid until exit.

Questions to Ask at the Interview

Strategic questions based on PLUS DENTAL's data — designed to show you've done your homework.

  • 1

    “What specific growth strategies does management have to compete with Align Technology's Invisalign?”

  • 2

    “Can you explain the company's unit economics and path to profitability, given the lack of public revenue data?”

  • 3

    “Given the acquisition by Straumann, how will equity be converted and what is the expected liquidity timeline?”

Community

Valuation Sentiment

Our model estimates -52% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.